Chemoinformaics analysis of Pentatriacontan-3-one
Molecular Weight | 506.944 | nRot | 32 |
Heavy Atom Molecular Weight | 436.384 | nRig | 5 |
Exact Molecular Weight | 506.543 | nRing | 0 |
Solubility: LogS | -3.738 | nHRing | 0 |
Solubility: LogP | 3.793 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 106 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 70 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 35 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 105.928 |
nHD | 0 | BPOL | 71.0925 |
QED | 0.473 |
Synth | 1.659 |
Natural Product Likeliness | 0.15 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.005 |
HIA | 0.002 |
CACO-2 | -4.302 |
MDCK | 0.0000185 |
BBB | 0.974 |
PPB | 0.904267 |
VDSS | 1.943 |
FU | 0.0703925 |
CYP1A2-inh | 0.9 |
CYP1A2-sub | 0.822 |
CYP2c19-inh | 0.42 |
CYP2c19-sub | 0.583 |
CYP2c9-inh | 0.359 |
CYP2c9-sub | 0.805 |
CYP2d6-inh | 0.145 |
CYP2d6-sub | 0.318 |
CYP3a4-inh | 0.124 |
CYP3a4-sub | 0.173 |
CL | 7.705 |
T12 | 0.337 |
hERG | 0.039 |
Ames | 0.009 |
ROA | 0.041 |
SkinSen | 0.554 |
Carcinogencity | 0.113 |
EI | 0.992 |
Respiratory | 0.505 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.564103 |